RNS Number : 2152J
Stenprop Limited
16 August 2019
 

 

 

 

                   STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP    JSE share code: STP

ISIN:  GG00BFWMR296

("Stenprop" or the "Company")

 

 

DEALINGS IN SECURITIES BY A DIRECTOR OF MAJOR SUBSIDIARIES AND BY ASSOCIATES OF DIRECTORS OF STENPROP

 

 

16 August 2019

 

Stenprop shareholders are referred to previous announcements in respect of the offer to receive the final dividend of 3.375 pence per share for the six months ended 31 March 2019 either as a cash dividend or a scrip dividend in return for Stenprop shares (the "Scrip Dividend"), the results of which were announced on Thursday, 15 August 2019. Shareholders are advised of the following information relating to dealings in securities by a director of major subsidiaries of the Company and by associates of directors of the Company in terms of the Scrip Dividend. Clearance to deal was granted in respect of all shares allocated in terms of the Scrip Dividend.

 

Name of director of major subsidiaries:

Neil Marais

Name of major subsidiaries:

Stenprop (UK) Limited and Stenprop (Germany) Limited

Transaction date:

16 August 2019

Class of securities:

Ordinary shares

Number of securities:

8,096

Deemed total value of the transaction:

GBP 8,706.20 (at a value of GBP 1.07537 per share)

Nature of transaction:

Election to receive shares pursuant to the Scrip Dividend as an off-market transaction

Nature and extent of director's interest:

Direct beneficial

 

Name of associate:

Millicent Limited

Name of director and relationship to director:

Patsy Watson, who is a discretionary beneficiary of the Swallow Trust which has a beneficial interest in Millicent Limited

Transaction date:

16 August 2019

Class of securities:

Ordinary shares

Number of securities:

131,251

Deemed total value of the transaction:

GBP 141,143.39 (at a value of GBP 1.07537 per share)

Nature of transaction:

Election to receive shares pursuant to the Scrip Dividend as an off-market transaction

Nature and extent of director's interest:

Indirect beneficial

 

Name of associate

Jabali Enterprises Limited

Name of director and relationship to director:

Paul Arenson, who is a discretionary beneficiary of the Lonat Trust which has a beneficial interest in Jabali Enterprises Limited

Transaction date:

16 August 2019

Class of securities:

Ordinary shares

Number of securities:

166,338

Deemed total value of the transaction:

GBP 178,874.90 (at a value of GBP 1.07537 per share)

Nature of transaction:

Election to receive shares pursuant to the Scrip Dividend as an off-market transaction

Nature and extent of director's interest:

Indirect beneficial

 

The Company utilised treasury shares to settle the Scrip Dividend. From today's date, the total number of treasury shares held by the Company is 15,937,130 ordinary shares and the total number of shares in issue less shares held in treasury is 282,838,045 ordinary shares.

 

 

 

For further information:

Stenprop Limited                                                                                                              44(0)20 3918 6600

Paul Arenson

James Beaumont

Julian Carey

 

Numis Securities Limited (Financial Adviser)                                                            44(0)20 7260 1000

Hugh Jonathan

Vicki Paine

 

Java Capital                                                                                                                       27 (0)11 722 3050

(JSE Sponsor)

            

About Stenprop:

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKPDNDBKDOFD